CSIMarket
 


Genocea Biosciences Inc   (GNCA)
Other Ticker:  
 

Cumulative Genocea Biosciences Inc 's Leverage Ratio for Trailing Twelve Months Period

GNCA's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

GNCA Leverage Ratio for Trailing Twelve Months Period

(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
Y / Y Equity Growth 602.89 % 201.44 % 87.23 % -49.55 % -86.46 %
Y / Y Total Liabilities Growth -67.87 % -67.72 % -68.5 % 125.77 % 155.37 %
Leverage Ratio for Trailing Twelve Months Period 1.91 2.99 5.17 9.46 7.44
Total Ranking # 3282 # 3773 # 3550 # 3999 # 3938
Seq. Equity Growth -54.26 % -28.43 % 832.9 % 130.14 % -80.38 %
Seq. Total Liabilities Growth -8.61 % 6.66 % -63.06 % -10.77 % -8.19 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Mar 31 2022
On the trailing twelve months basis Due to debt repayement of -8.61% Genocea Biosciences Inc decreased Leverage Ratio for Trailing Twelve Months Period in the I. Quarter to 1.91, below company's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Biotechnology & Pharmaceuticals industry 154 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Genocea Biosciences Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are GNCA's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 155
Sector # 950
S&P 500 # 3393


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
9.46 2.98 0.31
(Jun 30 2021)   (Dec 31 2016)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Mar 31 2022, within Biotechnology & Pharmaceuticals Industry Leverage Ratio for Trailing Twelve Months Period
Halozyme Therapeutics Inc   4.71 
Genocea Biosciences Inc   4.66 
Cidara Therapeutics Inc   4.62 
Peak Bio Inc   3.81 
Zivo Bioscience Inc   3.44 
Biondvax Pharmaceuticals Ltd   3.27 
Valneva Se  3.20 
Palisade Bio Inc   3.08 
Sorrento Therapeutics Inc   3.08 
Elutia inc   2.98 
Gamida Cell Ltd   2.81 
Avalon Globocare Corp   2.38 
Sab Biotherapeutics Inc   2.13 
Tenaya Therapeutics Inc   2.12 
Cannabis Global Inc.  2.09 
Gilead Sciences Inc   2.01 
Inhibrx Inc   1.92 
Acorda Therapeutics Inc   1.89 
Humacyte Inc   1.82 
Precision Biosciences Inc  1.76 
Alector Inc   1.66 
Erytech Pharma S a   1.56 
Nanostring Technologies Inc   1.52 
Codiak Biosciences Inc   1.42 
Innate Pharma Sa  1.41 
Ginkgo Bioworks Holdings Inc   1.41 
Eloxx Pharmaceuticals Inc   1.19 
Biogen Inc   1.19 
Ladrx Corporation  1.17 
Genfit S a   1.17 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com